Press Release
ZOLL Sponsors Second Annual “Chilling at the Beach” Conference on Temperature Management in Miami
04/11/2012
International Thought Leaders Discuss Emerging Science and Success of this Life-Saving Technology
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that it recently provided an educational grant to sponsor the second annual “Chilling at the Beach─Therapeutic Hypothermia and Temperature Management: Current and Future Directions” conference hosted by the University of Miami Miller School of Medicine.
During the two-day meeting, key thought leaders from around the world representing multiple specialties convened to discuss when therapeutic hypothermia is most appropriate to use and under what conditions temperature management is helpful for various indications.
The lectures and roundtable discussions attracted an international audience from pediatrics, nursing, cardiology, neurology, intensivists, surgeons, and emergency care physicians representing specialites such as acute myocardial infarction, sudden cardiac arrest, burn, surgery, neuro fever, and stroke. They came to learn about the latest temperature management science ranging from anti-shivering protocols to managing complications onto temperature management in emerging areas such as pediatric cardiac surgery and hypothermia for organ transplantation.
According to Course Director W. Dalton Dietrich, III, PhD, Scientific Director, the Miami Project to Cure Paralysis and Professor of Neurological Surgery, University of Miami Miller School of Medicine, the four conference tracks offered discussions on ICU and intra-operative temperature management, temperature management strategies, the future of temperature management, and bench-to-bedside cooling strategies.
“The 2012 Chilling at the Beach Miami Conference attracted over 130 attendees who discussed and debated a wide range of temperature-related topics important to the critical care of patients with acute and chronic injuries. The significance of this year’s conference is that clinicians, critical care nurses, and scientists from many diverse specialties gathered at one conference to learn and discuss the benefits of temperature management and therapeutic hypothermia for a widening range of indications,” said Dr. Dietrich. “The fields of post-cardiac arrest, head trauma, acute spinal injury, stroke, seizures, and organ transplantation were well-represented at the conference.”
“Temperature management is emerging as a standard of care for advancing critical care and improving outcomes in a range of life-altering situations,” said James Palazzolo, President of ZOLL Sunnyvale (Calif.) operations. “The conference afforded attendees the opportunity to evaluate a variety of cooling techniques, including intravascular, and the role they play in improving outcomes.”
The next “Chilling at the Beach” therapeutic hypothermia and temperature management conference for which ZOLL is providing an educational grant is to the University of Innsbruck. That symposia is scheduled for June 7-9 in Portoroz, Slovenia.
About ZOLL IVTM
ZOLL’s Intravascular Temperature Management (IVTM™) system provides cooling and warming from a catheter inserted into a patient’s vein. This provides better control of the core body temperature by directly cooling or warming the patient’s blood as it flows through the body. This catheter is connected to the Thermogard XP® console, which when used to induce hypothermia, circulates ice-cold saline solution inside a balloon catheter. After a period of therapeutic hypothermia, typically 12-24 hours, the system slowly and accurately rewarms the patient back to normal body temperature. Since the saline flows only within the catheter, no fluid is infused into the patient. The ZOLL IVTM system is efficient, precise and easy to use, and frees up clinical staff to attend to other patient needs.
ZOLL IVTM offers a variety of catheters with placement options to handle specific patient challenges. Options for catheter placement include femoral, subclavian, and internal jugular.
Copyright © 2012 ZOLL Medical Corporation. All rights reserved. IVTM and ZOLL are trademarks and/or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. All trademarks are the property of their respective owners.



